Rode Microphones, LLC et al. v. Zaxcom, Inc.

IPR2025-00232

The PTAB found all six challenged claims of Zaxcom’s ’902 patent unpatentable, adopting broader claim constructions and granting Zaxcom’s motion to amend with substitute claims 21‑26.

Jurisdiction
US PTAB
Case Number
IPR2025-00232
Judge(s)
Scott R. Boalick, Kalyan K. Deshpande, Lynne E. Pettigrew
Filing Date
12 April 2024

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Rode Microphones, LLC et al. vs Zaxcom, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2026-00043

American Airlines, Inc. et al.vsIntellectual Ventures II LLC

The PTAB denied American Airlines and Southwest Airlines’ petition to institute an IPR against Intellectual Ventures’ ’326 patent covering high‑data‑rate multi‑channel WLAN. The Board found no reasonable likelihood of success on any of the 18 challenged claims.

patentIPR2024-00909

Micron Technology, Inc. et al.vsYangtze Memory Technologies Company, Ltd.

The PTAB has instituted an inter partes review of claim 10 of Micron’s challenged 3D NAND patent, finding a reasonable likelihood of unpatentability over the Toyama reference.

patentIPR2024-00445

Comcast Corporation et al.vsEntropic Communications LLC

Comcast Cable Communications lost its IPR challenge against Entropic Communications, LLC regarding claims related to cable network service group management. The PTAB denied the petition, finding insufficient evidence that the claimed features were obvious in light of prior art references.

patentPGR2025-00004

Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.

Merck challenges Halozyme’s broad PH20 hyaluronidase patent, asserting lack of written description, enablement, and obviousness of the claimed protein variants.

patentIPR2024-00890

Abbott Diabetes Care Inc. et al.vsDexCom, Inc.

Abbott Diabetes Care Inc. successfully petitioned to institute IPR against DexCom, Inc.'s glucose monitoring patent (11020031). The Board found sufficient evidence for trial on 22 claims based on anticipation and obviousness over prior art from Zhang and Shin.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call